A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
Recruiting now · Phase 3
Conditions studied: Lymphoma
In brief
The study will evaluate the progression-free survival benefit of duvelisib monotherapy as compared to investigator's choice of gemcitabine or bendamustine in participants with relapsed/refractory nodal T cell lymphoma with TFH phenotype.
Key facts
- Study ID
- NCT06522737
- Run by
- SecuraBio
- People needed
- 124
- Starts
- 2025-05-19
- Expected to finish
- 2028-12-01
- Last updated by the study team
- 2026-04-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Universitair Ziekenhuis Gent (UZ Gent) — Ghent, Belgium (enrolling)
- UZ Leuven - Gasthuisberg Campus — Leuven, Belgium (enrolling)
- Vseobecna fakultni nemocnice — Prague, Czechia (enrolling)
- Aarhus University Hospital — Aarhus, Denmark (enrolling)
- Rigshospitalet Copenhagen — Copenhagen, Denmark (enrolling)
- Odense Hospital — Odense, Denmark (enrolling)
- UNICANCER - Centre Henri-Becquerel — Rouen, Normandy, France (enrolling)
- Institut Gustave Roussy — Villejuif, Vaillant, France (enrolling)
- CHU Cote de Nacre — Caen, France (enrolling)
- CHU Clermont-Ferrand — Clermont-Ferrand, France (enrolling)
- CHU Montpellier — Montpellier, France (enrolling)
- CHU Nantes — Nantes, France (enrolling)
- Hopital Pitie Salpetriere — Paris, France (enrolling)
- CHU Bordeaux — Pessac, France (enrolling)
- Centre Hospitalier Lyon Sud — Pierre-Bénite, France (enrolling)
- CHU PONTCHAILLOU-Haematology — Rennes, France (enrolling)
- Institut Curie Paris — Saint-Cloud, France (enrolling)
- Evangelisches Krankenhaus Essen-Werden — Essen, Germany (enrolling)
- Universitaetsmedizin Goettingen (UMG) - Klinik fuer Haematologie und Medizinische Onkologie — Goettigen, Germany (enrolling)
- Universitaetsklinikum Halle (Saale) — Halle, Germany (enrolling)
- Universitaetsklinikum Leipzig- Klinik und Poliklinik fuer Haematologie und Zelltherapie — Leipzig, Germany (enrolling)
- Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo - Alessandria — Alessandria, Italy (enrolling)
- Asst Papa Giovanni Xxiii Uo Ematologia — Bergamo, Italy (enrolling)
- Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy (enrolling)
- Ematologia Oncologia Instituto Pascale — Naples, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.